140 active
/
484 total (since 2015)
27
Phase 1 Active
90 total
57
Phase 2 Active
197 total
41
Phase 3 Active
154 total
36
Phase 4 Active
110 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
GSK 4 2 0
Avidity Biosciences, Inc. 3 0 0
Qilu Pharmaceutical Co., Ltd. 2 0 0
Roche 1 5 0
Pfizer 1 3 1
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1 2 0
BioVersys AG 1 1 0
Biotest 1 0 1
Scholar Rock, Inc. 1 0 0
Vasomune Therapeutics, Inc. 1 0 0
Beijing Continent Pharmaceutical Co, Ltd. 1 0 0
Akros Pharma Inc. 1 0 0
Arrowhead Pharmaceuticals 1 0 0
Eagle Pharmaceuticals, Inc. 1 0 0
Aptarion Biotech AG 1 0 0
NCT06488794 NOT YET RECRUITING
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
University Hospital Fattouma Bourguiba n=400
NCT04851015 RECRUITING
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
Todd C. Lee MD MPH FIDSA n=416
NCT07388680 NOT YET RECRUITING
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Beijing Continent Pharmaceutical Co, Ltd. n=298
NCT07327619 RECRUITING
A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Qilu Pharmaceutical Co., Ltd. n=420
NCT05722938 RECRUITING
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Biotest n=590
NCT05848713 RECRUITING
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
University of Manitoba n=4,000
NCT06592586 RECRUITING
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Minervax ApS n=338
NCT06229288 RECRUITING
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
Nantes University Hospital n=326
NCT07038200 RECRUITING
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Avidity Biosciences, Inc. n=200
NCT07326540 NOT YET RECRUITING
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
BioVersys SAS n=248
NCT07057037 RECRUITING
Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases
Inventera Inc. n=85
NCT06294600 RECRUITING
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
Hellenic Institute for the Study of Sepsis n=330
NCT04948203 ACTIVE NOT RECRUITING
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
University of Chicago n=60
NCT07252778 RECRUITING
Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes
Krzysztof Durkalec-Michalski n=30
NCT05843786 RECRUITING
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Hospices Civils de Lyon n=132
NCT06134492 RECRUITING
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Jena University Hospital n=616
NCT06774846 NOT YET RECRUITING
Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
Centre Hospitalier Universitaire Dijon n=600
NCT07152613 NOT YET RECRUITING
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
Qingyuan Zhan n=240
NCT07152587 NOT YET RECRUITING
Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)
Qingyuan Zhan n=1,500
NCT06269900 RECRUITING
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype
Nantes University Hospital n=450
NCT07089186 RECRUITING
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
Qilu Pharmaceutical Co., Ltd. n=80
NCT06980493 ACTIVE NOT RECRUITING
Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working
Sohag University n=30
NCT05696093 RECRUITING
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Assistance Publique - Hôpitaux de Paris n=628
NCT03031210 RECRUITING
Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
St. Justine's Hospital n=1,370
NCT05903352 RECRUITING
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
Assistance Publique - Hôpitaux de Paris n=328
NCT06859450 NOT YET RECRUITING
Local Antibiotic Delivery for Community Acquired Pneumonia
Copenhagen Respiratory Research n=36
NCT04256798 RECRUITING
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
University of Birmingham n=12,942
NCT06815679 NOT YET RECRUITING
Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC
Università degli Studi di Ferrara n=20
NCT06815549 NOT YET RECRUITING
An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation n=280
NCT05814432 RECRUITING
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Federal University of Health Science of Porto Alegre n=279
NCT06710080 NOT YET RECRUITING
Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia
Ottawa Heart Institute Research Corporation n=168
NCT06296212 RECRUITING
Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.
Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica n=178
NCT05759520 ACTIVE NOT RECRUITING
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
Fosun Adgenvax Biopharmaceutical Co.,Ltd. n=1,800
NCT06616259 NOT YET RECRUITING
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
Meng Qiu n=452
NCT03581370 RECRUITING
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
University Hospital, Toulouse n=80
NCT02735707 RECRUITING
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
UMC Utrecht n=20,000
NCT06162286 RECRUITING
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Zai Lab (Hong Kong), Ltd. n=100
NCT05706454 RECRUITING
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
KARE Biosciences n=324
NCT04357522 NOT YET RECRUITING
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd n=1,950
NCT05254990 TERMINATED
Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia
Dompé Farmaceutici S.p.A n=414
NCT03149640 COMPLETED
Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
University Hospital, Tours n=850
NCT02517489 COMPLETED
Community-Acquired Pneumonia : Evaluation of Corticosteroids
University Hospital, Tours n=952
NCT05397470 TERMINATED
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
Fulcrum Therapeutics n=260
NCT05905055 COMPLETED
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Meiji Seika Pharma Co., Ltd. n=126
NCT05204563 COMPLETED
Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)
Evopoint Biosciences Inc. n=450
NCT05526716 COMPLETED
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)
Merck Sharp & Dohme LLC n=1,080
NCT05444959 COMPLETED
The Impact of Exercise / Stress Stimuli on HMB Supplementation Efficacy
Poznan University of Physical Education n=130
NCT07183436 COMPLETED
Intra-articular Corticosteroids Are Widely Used for Adhesive Capsulitis, But Alternatives Are Required for Patients With Contraindications. Hyaluronic Acid (HA) and Ketorolac Have Shown Individual Benefits. However, Evidence on Their Combination Remains Limited.
Mahidol University n=56
NCT03915366 COMPLETED
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Hospital Universitario 12 de Octubre n=563
NCT05531149 TERMINATED
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Biotest n=107
NCT06168734 WITHDRAWN
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Venatorx Pharmaceuticals, Inc.
NCT04779242 COMPLETED
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
Paratek Pharmaceuticals Inc n=670
NCT06263881 COMPLETED
Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia
Materia Medica Holding n=370
NCT04884490 COMPLETED
The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh n=94
NCT05331885 TERMINATED
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Aridis Pharmaceuticals, Inc. n=24
NCT03474991 COMPLETED
KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP
Julia Bielicki n=510
NCT06817187 COMPLETED
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd n=1,110
NCT03583333 COMPLETED
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
Merck Sharp & Dohme LLC n=274
NCT06739382 COMPLETED
Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center
Beni-Suef University n=64
NCT03329092 COMPLETED
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
Pfizer n=422
NCT05077917 TERMINATED
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
Texas Tech University Health Sciences Center, El Paso n=22
NCT05420961 COMPLETED
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
Merck Sharp & Dohme LLC n=717
NCT04041791 COMPLETED
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
University of Oxford n=4,392
NCT05713292 COMPLETED
Pirfenidone in Adult Hospitalized Patients With COVID-19
Capital Medical University n=168
NCT04878055 COMPLETED
Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
Dompé Farmaceutici S.p.A n=287
NCT05485051 COMPLETED
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
Hospital do Coracao n=15,730
NCT04449588 TERMINATED
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
Staidson (Beijing) Biopharmaceuticals Co., Ltd n=369
NCT06390670 COMPLETED
The Effect of Colostrum Bovinum Supplementation in Endurance Athletes
Poznan University of Physical Education n=58
NCT04970719 WITHDRAWN
Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
NCT03384589 COMPLETED
CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study
University of British Columbia n=248
NCT03382548 COMPLETED
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
University of Oxford n=460
NCT04794803 TERMINATED
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
Dompé Farmaceutici S.p.A n=56
NCT04724044 COMPLETED
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
Hellenic Institute for the Study of Sepsis n=278
NCT05895773 COMPLETED
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Menoufia University n=78
NCT05656443 COMPLETED
Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
Fujian Akeylink Biotechnology Co., Ltd. n=1,246
NCT04629703 COMPLETED
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Rigel Pharmaceuticals n=280
NCT02389036 COMPLETED
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
The George Institute n=20,010
NCT03816956 COMPLETED
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
Aridis Pharmaceuticals, Inc. n=174
NCT04439071 TERMINATED
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
PTC Therapeutics n=189
NCT04917523 COMPLETED
Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above
China National Biotec Group Company Limited n=1,800
NCT04333420 COMPLETED
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
InflaRx GmbH n=399
NCT03439124 COMPLETED
Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
Basilea Pharmaceutica n=138
NCT05822180 COMPLETED
Evaluation of the Efficacy and Safety of Nano-S1
General Administration of Military Health, Tunisia n=116
NCT03551210 COMPLETED
Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia
R-Pharm n=342
NCT04372186 COMPLETED
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
Genentech, Inc. n=377
NCT03894046 COMPLETED
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex
Entasis Therapeutics n=207
NCT04071041 TERMINATED
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
Jordi Carratala n=39
NCT04643678 COMPLETED
Anakinra in the Management of COVID-19 Infection
Hamad Medical Corporation n=80
NCT04345289 TERMINATED
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
Thomas Benfield n=147
NCT04535063 COMPLETED
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno n=200
NCT04621058 COMPLETED
Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.
Bioaraba Health Research Institute n=108
NCT05445089 COMPLETED
Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients
Instituto Venezolano de Investigaciones Cientificas n=600
NCT05417997 COMPLETED
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
RAAS Nutritionals, LLC n=71
NCT04369469 TERMINATED
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia
Alexion Pharmaceuticals, Inc. n=202
NCT04236830 COMPLETED
Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars
Nourhan M.Aly n=108
NCT03896477 COMPLETED
Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants
PATH n=660
NCT04901676 SUSPENDED
Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
Hospital Israelita Albert Einstein n=612
NCT04901689 SUSPENDED
Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
Hospital Israelita Albert Einstein n=316
NCT05262309 COMPLETED
An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19
Fondazione Policlinico Universitario Agostino Gemelli IRCCS n=42
NCT04409262 COMPLETED
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
Hoffmann-La Roche n=649
NCT04362813 COMPLETED
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
Novartis Pharmaceuticals n=454
NCT04345861 TERMINATED
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
University Hospital, Montpellier n=7
NCT04346693 COMPLETED
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Burnasyan Federal Medical Biophysical Center n=320
NCT03829618 TERMINATED
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
Milton S. Hershey Medical Center n=29
NCT04372589 COMPLETED
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
University of Manitoba n=1,200
NCT03749226 TERMINATED
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
Hospital Universitari Joan XXIII de Tarragona. n=9
NCT04320615 COMPLETED
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
Hoffmann-La Roche n=452
NCT03545373 COMPLETED
Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)
London School of Hygiene and Tropical Medicine n=1,583
NCT03950856 COMPLETED
Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)
Merck Sharp & Dohme LLC n=2,340
NCT02265406 COMPLETED
PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone
Poitiers University Hospital n=354
NCT04347031 COMPLETED
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
Burnasyan Federal Medical Biophysical Center n=320
NCT04321278 COMPLETED
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
Hospital Israelita Albert Einstein n=440
NCT02714595 COMPLETED
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
Shionogi n=152
NCT03345992 COMPLETED
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
Hellenic Institute for the Study of Sepsis n=110
NCT04675086 WITHDRAWN
Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
Blessing Corporate Services, Inc
NCT04381858 COMPLETED
Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia
Centenario Hospital Miguel Hidalgo n=196
NCT03032380 COMPLETED
Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
Shionogi n=300
NCT02736240 COMPLETED
Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
Walvax Biotechnology Co., Ltd. n=2,760
NCT04500067 COMPLETED
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
Biopharma Plasma LLC n=76
NCT04403685 TERMINATED
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Beneficência Portuguesa de São Paulo n=129
NCT04327401 TERMINATED
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
Hospital Sirio-Libanes n=299
NCT03197376 COMPLETED
Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants
PATH n=2,250
NCT04347512 WITHDRAWN
EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
University Hospital, Strasbourg, France
NCT02494999 COMPLETED
A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
Jiangsu Province Centers for Disease Control and Prevention n=1,200
NCT02493764 COMPLETED
Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Merck Sharp & Dohme LLC n=537
NCT04347733 COMPLETED
Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for Shoulder
Veterans Health Service Medical Center, Seoul, Korea n=30
NCT04261517 COMPLETED
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
Shanghai Public Health Clinical Center n=30
NCT02679573 COMPLETED
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=860
NCT04278248 COMPLETED
Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd n=1,940
NCT02943902 COMPLETED
Reduced PCV Dosing Schedules in South African Infants
University of Witwatersrand, South Africa n=600
NCT02559310 COMPLETED
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
Nabriva Therapeutics AG n=551
NCT02813694 COMPLETED
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Nabriva Therapeutics AG n=738
NCT02134106 WITHDRAWN
Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
Tan Tock Seng Hospital
NCT03582007 TERMINATED
Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
Polyphor Ltd. n=2
NCT03409679 TERMINATED
Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa
Polyphor Ltd. n=41
NCT02764411 TERMINATED
Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
The Hospital for Sick Children n=6
NCT02531438 COMPLETED
Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
Paratek Pharmaceuticals Inc n=774
NCT03006679 WITHDRAWN
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Melinta Therapeutics, Inc.
NCT02605122 TERMINATED
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=97
NCT02906722 TERMINATED
Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia
Assistance Publique - Hôpitaux de Paris n=7
NCT03622450 COMPLETED
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
Nourhan Hassan Osama Thuraya Mohamed n=40
NCT02806141 TERMINATED
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
Hat Yai Medical Education Center n=204
NCT02605096 TERMINATED
Pilot Study to Test the Feasibility of the Use of MRI in Suspected Scaphoid Fractures
Guy's and St Thomas' NHS Foundation Trust n=10
NCT02725255 COMPLETED
Design and Clinical Evaluation of a School Meal With Deworming Properties
Kenya Medical Research Institute n=326
NCT02269644 WITHDRAWN
A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
Durata Therapeutics Inc., an affiliate of Allergan plc
Data: ClinicalTrials.gov